HEPARIN SODIUM 20000UNIT/500ML IN DEXT 5% INJ 40 UNIT — DIN 00894648
HEPARIN SODIUM : 40 UNIT · HOSPIRA HEALTHCARE ULC · SOLUTION · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is HEPARIN SODIUM 20000UNIT/500ML IN DEXT 5% INJ?
HEPARIN SODIUM 20000UNIT/500ML IN DEXT 5% INJ 40 UNIT contains HEPARIN SODIUM : 40 UNIT. It is listed in the Health Canada Drug Product Database under DIN 00894648, held by HOSPIRA HEALTHCARE ULC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 22-Nov-2018. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Heparin cost around the world?
Heparin is listed on 6 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Greece publishes a producer price (ex-factory); Romania publishes a max producer price. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 3 | 26 | USD███.██ |
| United Kingdom | hospital | 14 | 14 | GBP███.██ |
| Romania | max producer price | 3 | 6 | RON███.██ |
| South Africa | single exit price | 2 | 2 | ZAR███.██ |
| Australia | ex-manufacturer | 1 | 1 | AUD███.██ |
| Greece | producer price (ex-factory) | 1 | 1 | EUR███.██ |
50 pack listings across 24 brand entries and 6 price bases, refreshed 08 Sep 2026. Ranges span every Heparin pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Heparin in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
10 holders have a Canadian DIN containing Heparin, across 32 DINs, of which 10 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| FRESENIUS KABI CANADA LTD | 4 | 3 | HEPARIN SODIUM INJECTION, USP | Sourceable in Canada |
| PFIZER CANADA ULC | 6 | 2 | HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION, HEPARIN SODIUM INJECTION USP | Sourceable in Canada |
| LEO PHARMA INC | 4 | 2 | HEPARIN LEO 100UNIT/ML, HEPARIN LEO INJ 10000UNIT/ML, HEPARIN LEO INJ 1000UNIT/ML, HEPARIN LEO INJ 25000UNIT/ML | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 3 | 1 | HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE), HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | Sourceable in Canada |
| STERIMAX INC | 1 | 1 | HEPARIN SODIUM INJECTION USP | Sourceable in Canada |
| STERINOVA INC. | 1 | 1 | HEPARIN SODIUM INJECTION USP | Sourceable in Canada |
| HOSPIRA HEALTHCARE ULC | 5 | 0 | HEPARIN LOCK FLUSH SOLUTION INJECTION USP, HEPARIN SODIUM 20000UNIT/500ML IN DEXT 5% INJ, HEPARIN SODIUM 25000UNIT/500ML IN 5% DEXTR INJ, HEPARIN SODIUM 5000UNIT/500ML IN SODIUM CHLORIDE 0.9% | No marketed DIN |
| SCHERING-PLOUGH CANADA INC | 5 | 0 | HEPALEAN 10,000 USP, HEPALEAN 1000 USP, HEPALEAN 25,000 USP, HEPALEAN-LOK 10 USP, HEPALEAN-LOK 100 USP | No marketed DIN |
| CHOAY LAB | 2 | 0 | CALCIPARINE INJ 20000IU/AMP, CALCIPARINE INJ 5000IU | No marketed DIN |
| ORGANON TEKNIKA CANADA INC. | 1 | 0 | CALCILEAN INJ 20000UNIT/0.8ML | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 40 UNIT |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Heparin |
|---|---|
| ATC code | B01AB01 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00894648 |
|---|---|
| DIN (unpadded, as printed on some documents) | 894648 |
| Brand name | HEPARIN SODIUM 20000UNIT/500ML IN DEXT 5% INJ |
| Generic / active ingredient | HEPARIN SODIUM : 40 UNIT |
| Market authorization holder | HOSPIRA HEALTHCARE ULC |
| Health Canada schedule | Ethical |
| ATC code | B01AB01 |
| ATC anatomical main group | B — Blood and blood-forming organs |
| ATC therapeutic subgroup | B01AB |
| Current status | CANCELLED POST MARKET |
| Status date | 22-Nov-2018 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Heparin in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by B. BRAUN MEDICAL INC, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for HEPARIN SODIUM 20000UNIT/500ML IN DEXT 5% INJ
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
10 of 32 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| HEPARIN LEO 100UNIT/ML | 100 UNIT | LIQUID | LEO PHARMA INC | MARKETED | 00727520 |
| HEPARIN LEO INJ 1000UNIT/ML | 1000 UNIT | LIQUID | LEO PHARMA INC | MARKETED | 00453811 |
| HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION | 2 UNIT | SOLUTION | PFIZER CANADA ULC | MARKETED | 01990748 |
| HEPARIN SODIUM INJECTION USP | 5000 UNIT / 0.5 ML | SOLUTION | STERINOVA INC. | MARKETED | 02456958 |
| HEPARIN SODIUM INJECTION USP | 5000 UNIT / 0.5 ML | SOLUTION | STERIMAX INC | MARKETED | 02548488 |
| HEPARIN SODIUM INJECTION USP | 10000 UNIT | SOLUTION | PFIZER CANADA ULC | MARKETED | 02382326 |
| HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | 1000 UNIT | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | 02303086 |
| HEPARIN SODIUM INJECTION, USP | 10000 UNIT | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | 02264307 |
| HEPARIN SODIUM INJECTION, USP | 1000 UNIT | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | 02264315 |
| HEPARIN SODIUM INJECTION, USP | 10000 UNIT | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | 02392453 |
2 · Same class — other molecules in ATC B01AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Enoxaparin | AXBERI · AXBERI HP · ELONOX · ELONOX HP · +9 more | 46 | 44 | Yes |
| Tinzaparin | INNOHEP · INNOHEP DISP.SYR.-11700 ANTI-XA IU/ML · LOGIPARIN LIQ SC 10000 FXAIU/ML | 13 | 11 | Yes |
| Heparin | CALCILEAN INJ 20000UNIT/0.8ML · CALCIPARINE INJ 20000IU/AMP · CALCIPARINE INJ 5000IU · HEPALEAN 10,000 USP · +17 more | 32 | 10 | Yes |
| Dalteparin | FRAGMIN · FRAGMIN INJ.-LIQ 2500 IU(ANTI-XA)/ML | 13 | 10 | Yes |
| Heparin, Combinations | HEPARIN SOD AND 0.9% SOD CHLORIDE INJ · HEPARIN SODIUM & 5% DEXTROSE INJECTION LIQ · HEPARIN SODIUM & DEXTROSE 5% IN VIAFLEX LIQ · HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ · +4 more | 8 | 4 | Yes |
| Antithrombin | ANTITHROMBIN III IMMUNO · ANTITHROMBIN III NF · THROMBATE III · THROMBATE III PWS IV 1000IU/VIAL · +1 more | 7 | 2 | Yes |
| Danaparoid | ORGARAN | 1 | 1 | Yes |
| Nadroparin | FRAXIPARINE · FRAXIPARINE FORTE | 8 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC B01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| B01AF | Apixaban · Edoxaban · Rivaroxaban | 159 | 121 |
| B01AC | Abciximab · Acetylsalicylic Acid · Cangrelor · Clopidogrel · Combinations · +10 more | 158 | 66 |
| B01AA | Acenocoumarol · Warfarin | 62 | 16 |
| B01AE | Argatroban · Bivalirudin · Dabigatran Etexilate · Lepirudin | 18 | 11 |
| B01AX | Caplacizumab · Defibrotide · Fondaparinux | 10 | 5 |
| B01AD | Alteplase · Ancrod · Anistreplase · Drotrecogin Alfa · Reteplase · +3 more | 22 | 4 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is HEPARIN SODIUM 20000UNIT/500ML IN DEXT 5% INJ called?
The same molecule, Heparin, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| DBL Heparin Sodium | Latin | Australia |
| Thrombophob Gel | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.